Pericontusion axon sprouting is spatially and temporally consistent with a growth-permissive environment after traumatic brain injury.
We previously reported that pericontusional extracellular chondroitin sulfate proteoglycans (CSPGs) are profoundly reduced for 3 weeks after experimental traumatic brain injury, indicating a potential growth-permissive window for plasticity. Here, we investigate the extracellular environment of sprouting neurons after controlled cortical impact injury in adult rats to determine the spatial and temporal arrangement of inhibitory and growth-promoting molecules in relation to growth-associated protein 43-positive (GAP43+) neurons. Spontaneous cortical sprouting was maximal in pericontused regions at 7 and 14 days after injury but absent by 28 days. Perineuronal nets containing CSPGs were reduced at 7 days after injury in the pericontused region (p < 0.05), which was commensurate with a reduction in extracellular CSPGs. Sprouting was restricted to the perineuronal nets and CSPG-deficient regions at 7 days, indicating that the pericontused region is temporarily and spatially permissive to new growth. At this time point,GAP43+ neurons were associated with brain regions containing cells positive for polysialic acid neural cell adhesion molecule but not with fibronectin-positive cells. Brain-derived neurotrophic factor was reduced in the immediate pericontused region at 7 days. Along with prior Western blot evidence, these data suggest that a lowered intrinsic growth stimulus, together with a later return of growth-inhibitory CSPGs, may contribute to the ultimate disappearance of sprouting neurons after traumatic brain injury.
Harris
Neil G
NG
UCLA Brain Injury Research Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-7039, USA. ngharris@mednet.ucla.edu
Mironova
Yevgeniya A
YA
Hovda
David A
DA
Sutton
Richard L
RL
D000818:Animals; D001369:Axons; D015153:Blotting, Western; D001930:Brain Injuries / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism; D002540:Cerebral Cortex / Q000293:injuries* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D011508:Chondroitin Sulfate Proteoglycans / Q000378:metabolism; D015536:Down-Regulation; D019922:GAP-43 Protein / Q000378:metabolism; D008297:Male; D009415:Nerve Net / Q000473:pathology / Q000503:physiopathology; D009416:Nerve Regeneration; D019006:Neural Cell Adhesion Molecules / Q000378:metabolism; D009473:Neuronal Plasticity; D009474:Neurons / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012794:Sialic Acids / Q000378:metabolism; D013997:Time Factors; D014018:Tissue Distribution; D014949:Wounds, Nonpenetrating / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*
D019208:Brain-Derived Neurotrophic Factor; D011508:Chondroitin Sulfate Proteoglycans; D019922:GAP-43 Protein; D019006:Neural Cell Adhesion Molecules; D012794:Sialic Acids; C021319:polysialic acid